Drugs / GSK1940029
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01938482 | Oct 2013 → Feb 2015 | acne | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01984801 | Oct 2013 → Apr 2015 | acne | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1940029 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01938482 ↗ |
| Route | Topical | “Will be supplied as gel for topical application” NCT01938482 ↗ |